Active (not recruiting) Phase 1 2024-513285-19-00

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Phase 1 – testing safety in a small group of people

Conditions: Pancreatic Ductal Adeno Carcinoma Colorectal Cancer Non- Small Cell Lung Cancer (NSCLC) Renal Cell Carcinoma

Sponsor: Kura Oncology Inc.

trial.available_in:

БГ

Overview

Trial status: Authorised

Who can participate

Age group: 65+ years, 18-64 years Gender: Female, Male Target enrollment: 66 participants

France (1)

Germany (1)

Italy (1)

Spain (1)

Status

Active (not recruiting)

Phase

Phase 1

Study type

INTERVENTIONAL

Sex

Male and female

Minimum age

18 Years

Healthy volunteers

Start date

30.01.2025

Registry ID

2024-513285-19-00

Source

euclinicaltrials.eu

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.